Tag Archives: drugs

A Must Read Book About the Players That Drove the Opiod Epidemic from the Get Go

Dream Land is an engaging read–well written and well researched.  Sam Quinones, author and journalist, traces the Opiod epidemic from the first distillation of Morphine from opium in 1804 to the present.  He even includes the Opium Wars between the … Continue reading

Posted in opiod epidemic, pharmaceutical companies, prescription drugs | Tagged , , , , , , , , , | Leave a comment

Pharmaceutical costs–what’s behind them

I have been recovering from my hip replacement surgery with a few post surgical complications from another ailment.  That said, I could not resist sharing this link from the Kaiser Family Foundation news service. They are a 501© 3 non-profit … Continue reading

Posted in consumer protection, pharmaceutical companies, prescription drugs, technology and pharmaceutical costs, Uncategorized | Tagged , , , , , , | Leave a comment

The American Health Care Machine and You: A Call To Conscience not Calculators

The American Health Care Machine and You:  A Call to Conscience not Calculators ©.    Our health care system fails us.  It fails us not only as patients it fails the many health professionals who are also victims of the rules, … Continue reading

Posted in Affordable Care Act, aging, community action, Health Care Reform, health insurance, long-term care, Medicare, patient care, public dialogue, quality of care | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

See How America’s Health Care Costs and Outcomes Compare to Others

I have been busy on a project and not blogging as frequently.  Given the discussions about health care in the election, however, I thought people would find this brief graphic video by the Kaiser Family Foundation of interest.  It shows … Continue reading

Posted in Affordable Care Act, Economy, Health Care Reform, health insurance, patient safety, policy and politics, politics, prescription drugs, public dialogue, quality of care, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

Who Have We Become?

Speaker Paul Ryan’s new call to repeal the Affordable Care Act is either a bluff or completely blind and heartless. Imperfect as it is—and the legislation certainly has flaws—the Act assures people have access to health insurance even with a … Continue reading

Posted in Affordable Care Act, Health Care Reform, health insurance, medical bankruptcy, Medicare, patient safety, pharmaceutical companies, politics | Tagged , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Congress Tackles Drug Prices: Much Bipartisan Support; and Recent Trends in Drug Costs Here and What Other Countries Pay

Finally it looks like Congress might just re-visit Medicare Part D and let Medicare negotiate rates with drug companies.   See charts below: http://www.statnews.com/2015/12/01/stat-harvard-drug-prices-poll/  The VA and Medicaid can negotiate rates. Senate Special Committee on Aging holds drug costs hearing December … Continue reading

Posted in aging, Economy, media, Medicare, pharmaceutical companies, policy and politics, politics, prescription drugs, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Drug Costs and Congress: Investments, Contributions and You

A scathing new article on Congress and its financial conflicts of interests with drug and device companies appears in STAT, a news firm specializing in health and science. It examines Senators and Representatives who have oversight of the FDA and … Continue reading

Posted in health insurance, medical bankruptcy, Medicare, pharmaceutical companies, policy and politics, prescription drugs, public dialogue, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Drug Clinical Trials, Comparative Effectiveness, and much more

In 2013, I ran a 2 column series on how pharmaceutical products are tested and evaluated before going on the market (see link below). In light of the current discussions about drug prices, here are some things you might be … Continue reading

Posted in business, consumer protection, pharmaceutical companies, prescription drugs | Tagged , , , , , , , , , , , , , , , , | Leave a comment

What You CAN Do About Prescription Drug Costs

What American’s Think About Prices and What You Can Do                      “Corporations now spend at least $2.6 billion a year lobbying Congress—more than the $2 billion taxpayers spend funding the House and the Senate.”  The Week, July 31, 2015 What … Continue reading

Posted in consumer protection, Economy, health insurance, medical bankruptcy, Medicare, patients' voice, policy and politics, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , | Leave a comment

Did You Know? New Series on Long-term Care. PART I: Medicare Can’t Negotiate Drug Prices—VA and Medicaid Can

The Presidential election season is once again upon us.  The Affordable Care Act deals with some Medicare issues, but some key ones are not addressed. Pharmaceutical costs and long-term care are two of them.  Here is a question you can … Continue reading

Posted in business, consumer protection, Health Care Reform, medical bankruptcy, Medicare, patients' voice, policy and politics, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , | Leave a comment